BOXED WARNING Increased mortality in elderly patients with dementia-related psychosis; suicidal thoughts and behaviors in pediatric/young adults. Not approved for dementia-related psychosis; not established in pediatrics.
FDA dosing
Population
Start
Target
Max
Schizophrenia
Adults
42 mg QD
42 mg QD
42 mg QD
Bipolar depression (I or II; monotherapy or adjunct to lithium/valproate)
Adults
42 mg QD
42 mg QD
42 mg QD
Major depressive disorder (adjunct to antidepressants)
Adults
42 mg QD
42 mg QD
42 mg QD
Renal Undefined
Hepatic Moderate or severe (Child-Pugh B/C): 21 mg QD. Mild (A): no adjustment.
Instructions
Take with or without food.
No dose titration needed.
Cautions
Cerebrovascular reactions (stroke, TIA) in elderly with dementia